Life Science News

Cloud DX and partner Maxwell Telecare sign three new clinics for Remote Patient Monitoring deployment, expanding on its Maxwell partnershipNews in SummaryExpansion of Cloud DX's Patient-First™ program within the Maxwell networkReimbursed RPM programs have the potential to impact 33% of American adults1New contracts strengthen partnership, bringing Maxwell projects to five clinics in three monthsCloud DX Cloud DX, ...

Cloud DX and partner Maxwell Telecare sign three new clinics for Remote Patient Monitoring (RPM) deployment, expanding on its Maxwell partnership

News in Summary

  • Expansion of Cloud DX's Patient-First™ program within the Maxwell network
  • Reimbursed RPM programs have the potential to impact 33% of American adults1
  • New contracts strengthen partnership, bringing Maxwell projects to five clinics in three months

Cloud DX (TSXV:CDX)(OTC:CDXFF), Cloud DX, a leading Virtual Care platform in North America, and partner Maxwell Telecare announce three new contracts with US based Primary Care practices in Illinois. These three clinics will deploy Connected Health™ to patients for reimbursed Remote Patient Monitoring and Chronic Care Management. As part of its Patient-First™ program, Cloud DX works with physician partners to establish criteria indicating a patient will benefit from RPM to control exacerbations, improve quality of life, and avoid hospitalization and ER visits. These deployments follow recent agreements with seven clinical facilities in the last three months, including University of Waterloo, two previous Maxwell Telecare clinics, Hamilton Health Sciences, and an Ontario Pulmonary Rehabilitation Clinic. In December 2021, Cloud DX announced an exclusive partnership with Medtronic Canada to provide virtual care services to up to 1 million available patients in Canada

Dr. Andrew Rosenson, President of Maxwell telecare states: "As a physician, preventing patients from being hospitalized or re-admitted is excellent for both patients and the healthcare system. Within the Maxwell network, we successfully prevent 80% of re-hospitalizations already and look forward to improving this rate. For chronic care patients especially, adding Connected Health™ into these new practices will significantly reduce exacerbations and improve patient lives significantly."

"We're excited to add new Maxwell Telecare clinical partners to our Connected Health™ platform," says Robert Kaul, CEO and Founder of Cloud DX. "This important partnership continues to grow. We are making healthcare better, supporting aging in place, and providing easy and timely care escalation. As Maxwell improves patient care, Connect Health™ can offer Maxwell providers up to a 9.4x return on investment2, meaning fewer emergency hospital visits and subsequent admissions. It is truly a win-win."

Cloud DX expects to earn approximately $900 CAD in annual recurring revenue (ARR) per patient under current US reimbursement codes for remote monitoring of chronic disease patients. The company aims to be cash flow positive3 upon reaching approximately 10,000 enrolled and compliant US RPM patients.

Footnotes:

  1. Hajat, C., & Stein, E. (2018). The global burden of multiple chronic conditions: A narrative review. Preventive medicine reports, 12, 284-293. https://doi.org/10.1016/j.pmedr.2018.10.008
  2. Return on invlmaestment calculations are based upon Maxwell Telecare internal financial estimates.
  3. Forward looking statement. Please see disclaimer in the current Investor Presentation available at ir.clouddx.com

About Cloud DX

Accelerating virtual healthcare, Cloud DX is on a mission to make healthcare better for everyone. Our Connected Health TM remote patient monitoring platform is used by healthcare enterprises and care teams across North America to virtually manage chronic disease, enable aging in place, and deliver hospital-quality post-surgical care in the home. Our partners achieve better healthcare and patient outcomes, reduce the need for hospitalization or re-admission, and reduce healthcare delivery costs through more efficient use of resources. Cloud DX is the co-winner of the Qualcomm Tricorder XPRIZE, a 2021 Edison Award winner, a Fast Company "World Changing Idea" finalist, and one of "Canada's Ten Most Prominent Telehealth Providers." In 2021, Cloud DX became an exclusive partner of Medtronic Canada.

Cloud DX Investor Site https://ir.clouddx.com/overview/default.aspx

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

# # #

For inquiries please contact:

Janine Scott
Marketing Lead
888-543-0944
janine.scott@CloudDX.com

SOURCE: Cloud DX Inc.



View source version on accesswire.com:
https://www.accesswire.com/682047/Cloud-DX-Announces-Contracts-with-US-Primary-Care-Clinics

News Provided by ACCESSWIRE via QuoteMedia

CDX:CA
Cloud DX

Cloud DX

Overview

The COVID-19 global pandemic shook traditional healthcare structures on a global scale in 2020. There has been an urgent need for integrated systems to manage the influx of patients and new social distancing measures, which forced many to delay seeking in-person medical attention. In identifying this gap in the healthcare system, digitally driven telemedicine companies are leading the way to innovate and improve healthcare for all in this increasingly digital age.

By 2022, the global healthcare market is forecasted to grow to US$11.9 trillion, with the digital healthcare sector to grow by a projected compound annual growth rate (CAGR) of 38 percent by 2026. In dealing with the aftermath of this pandemic, investing in healthcare and wellness technology is investing in the healthcare systems we’ve needed for a long time.

Keep reading... Show less
Cloud DX: Digital and Virtual Healthcare, CEO Clip Video

Cloud DX: Digital and Virtual Healthcare, CEO Clip Video

Cloud DX Inc. (TSXV: CDX Robert Kaul, CEO & Founder, speaks about the company's game-changing partnership with Medtronic, a global leader in healthcare technology.

Keep reading... Show less
Cloud DX Announces Voluntary Extension of Lock-up Agreements with Company Insiders

Cloud DX Announces Voluntary Extension of Lock-up Agreements with Company Insiders

News in Summary

  • Cloud DX insiders (as defined by the TSX Venture Exchange) holding approximately 33% of the issued and outstanding shares of Cloud DX Inc. voluntarily extend the release date under lock-up agreements
  • This six-month voluntary extension of their resale restrictions indicates that the board and management are confident about the company's growth prospects

Cloud DX Inc. (the "Company" or "Cloud DX") (TSXV:CDX) (OTCQB:CDXFF), announces today that certain company ‘insiders' (as defined by the TSX Venture Exchange) have voluntarily agreed to extend the release dates under the lock-up agreements they entered into in connection with the Company's ‘Qualifying Transaction' which closed on April 15, 2021. Insiders holding approximately 33% of the issued and outstanding shares of the Company have agreed to extend the lock-up to be effective until October 31, 2022

Keep reading... Show less
Cloud DX Inc. Announces Update to Brokered Private Placement

Cloud DX Inc. Announces Update to Brokered Private Placement

Cloud DX Inc. ("Cloud DX" or the "Company") (TSXV:CDX) announces that it has updated the terms of its private placement previously announced on January 4, 2022 of Convertible Debenture Units (the "Updated Offering") with Echelon Wealth Partners Inc. as lead agent and sole book runner (the "Agent"). The Company expects the initial closing of the Updated Offering will be on or about January 25, 2022

In connection with the Updated Offering the Agent will offer for sale up to 3,000 convertible debenture units of the Company (the "Convertible Debenture Units") at a price of $1,000 per Convertible Debenture Unit for aggregate gross proceeds of up to $3,000,000. The Agent has been granted an option to sell up to 450 additional Convertible Debenture Units for maximum aggregate gross proceeds under the Updated Offering of $3,450,000. Pursuant to the Updated Offering, each Convertible Debenture Unit will be comprised of $1,000 principal amount unsecured convertible debenture (each, a "Debenture") and 1,430 common share purchase warrants of the Company (each, a "Warrant"). The Debentures will mature on the date that is 36 months from the date of issuance (the "Maturity Date") and shall bear interest at a simple rate of 10% per annum. Interest will be payable quarterly on the last business day of each quarter, commencing on March 31, 2022. The principal amount of the Debentures, or any portion thereof, may be converted at the election of the holder thereof into common shares in the capital of the Company ("Common Shares") at a conversion price of $0.35 per Common Share (the "Conversion Price") at any time prior to the Maturity Date. Each Warrant will entitle the holder thereof to acquire one Common Share at a price of $0.50 per Common Share for a period of 24 months from the closing date of the Updated Offering.

Keep reading... Show less
Cloud DX Receives Partnership Funding for Clinical Research of Next Generation Wrist-Worn Vital-Sign Monitoring Device

Cloud DX Receives Partnership Funding for Clinical Research of Next Generation Wrist-Worn Vital-Sign Monitoring Device

The New Brunswick Health Research Foundation (NBHRF) partners with Cloud DX to fund Calibration and Validation research of its patented Pulsewave 2.0, a Non-Invasive Vital Sign Monitoring Device

News in Summary

Keep reading... Show less
Cloud DX Announces Multi-Year Contract with Ontario Clinic

Cloud DX Announces Multi-Year Contract with Ontario Clinic

Cloud DX Announces Multi-Year Contract with Ontario Clinic

Combining Telehealth and Remote Monitoring, Cloud DX's Connected Health™ enables the clinic to deliver virtual physical rehabilitation safely and efficiently in patient homes

Keep reading... Show less
JustKitchen Reports Annual 2021 Financial Results

JustKitchen Reports Annual 2021 Financial Results

TSXV: JK

The Company's Volume of Retail Customer Food Orders Grew by 26% From the Third Quarter to the Fourth Quarter as its Number of Ghost Kitchens Increased from 17 to 20 Locations for the Period Ending September 30, 2021

Keep reading... Show less
Contakt World - Corporate Update

Contakt World - Corporate Update

  • Demand for HealthCheck, Contakt's marquee solution, continues to grow in the face of the Omicron variant-driven wave of COVID-19 and increasing vaccine mandates and requirements in numerous jurisdictions
  • HealthCheck has added over 20 new customers and has renewed over 130 customer subscriptions within the past 3 months, with nearly 800 customers in total, servicing over 100,000 users in the US alone
  • HealthCheck alone generated nearly $1.35 million CAD in revenue in calendar 2021 (figures unaudited)
  • HealthCheck 3.0 has been officially released, adding vaccine passport, COVID-19 test tracking capabilities, and several improvements to its population management dashboard.
  • Contakt is looking to broaden its portfolio entering 2022, looking to acquire and partner with other SaaS companies in the healthcare sector and beyond

Contakt World Technologies Corp. (CSE: HELP) (OTC Pink: TLOOF) (FSE: B2I0) (the "Company", "Contakt" or "Contakt World"), a SaaS company committed to delivering a diverse suite of subscription based software solutions for healthcare and other industries, is pleased to provide a general corporate update for its shareholders.

HealthCheck
Contakt's COVID Compliance Solution, Stratum Health ("HealthCheck"), has seen significant growth in new customers and renewals over the past 90 days, primarily driven by the recent surge of COVID-19 Omicron variant globally. HealthCheck has added nearly 20 new enterprise clients since October, and new sales continue to growth month over month. Many of HealthCheck's largest clients, including Atlanta County Public Schools, with close to 50,000 users (students and school staff), have extended or renewed their annual contracts, continuing to drive revenue.

Keep reading... Show less
JustKitchen Announces Opening of Second Hong Kong Location and Sanchong Ghost Kitchen in Taiwan

JustKitchen Announces Opening of Second Hong Kong Location and Sanchong Ghost Kitchen in Taiwan

TSXV: JK   OTCQB: JKHCF   FRA: 68Z

The Company Has Also Launched a Food Truck Featuring DJ Khaled's "Another Wing" Food Brand and is Planning to Open Two New Ghost Kitchen Locations in Taiwan in the Near Future

Keep reading... Show less
Nanalysis Named to 2022 OTCQX Best 50

Nanalysis Named to 2022 OTCQX Best 50

Nanalysis Scientific Corp. ( TSXV:NSCI , OTCQX:NSCIF, FRA:1N1) ("Nanalysis" or the "Company") is pleased to announce it has been named to the 2022 OTCQX® Best 50, a ranking of top performing companies traded on the OTCQX Best Market last year.

Keep reading... Show less
NANALYSIS SCIENTIFIC CORP. ANNOUNCES MARKETED PUBLIC OFFERING OF UP TO C$8 MILLION

NANALYSIS SCIENTIFIC CORP. ANNOUNCES MARKETED PUBLIC OFFERING OF UP TO C$8 MILLION

/NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES /

Nanalysis Scientific Corp. (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1) (" Nanalysis ", or the " Company ") is pleased to announce that it has filed a preliminary short form prospectus with the securities commissions or similar regulatory authorities in each of the provinces of Canada except for the Province of Québec (the " Canadian Jurisdictions "), in connection with a best efforts marketed public offering (the " Offering ") of common shares (the " Common Shares ") of the Company at an offering price of $1.10 per Common Share for gross proceeds of up to approximately $8,000,000 .

Keep reading... Show less
Nanalysis Enters into a Letter of Intent to Acquire Quad Systems AG

Nanalysis Enters into a Letter of Intent to Acquire Quad Systems AG

Nanalysis Scientific Corp. ( TSXV:NSCI , OTCQX:NSCIF, FRA:1N1) ("Nanalysis" or the "Company") is pleased to announce that it has entered into a letter of intent to acquire QUAD Systems AG (Quad Systems), a Zurich -based Nuclear Magnetic Resonance (NMR) company focused on high-field NMR for pharmaceutical and other vertical markets.

Keep reading... Show less

Latest Press Releases

Related News

×